The research focused on the pediatric use of molecular-targeted cancer treatments would drive forward, and the FDA would be told to expedite drug studies for adolescence diseases, under a measure that Congress passed just last week. The Pediatric Research Equity Act (PREA) of 2003 was endorsed to nurture the development of innovative treatments for childhood diseases. But, PREA didn’t include cancer because treatments that attack cancer’s genetic structure were unavailable at the time.
On Wednesday, the Research to Accelerate Cures and Equity (RACE) for Children Act, was approved as part of the bigger FDA user fees reauthorization bill, would modify PREA to make sure that research is conducted on pediatric uses of molecular-targeted cancer treatments that are already approved for adults.
U.S. Sens. Marco Rubio (R-FL), Michael Bennet (D-CO), Chris Van Hollen (D-MD) and Cory Gardner (R-CO) introduced the RACE for Children Act in the Senate. With the measure’s approval, it will head to the president’s desk for approval.
“Pediatric cancer is a leading cause of death by disease among children and yet children do not have the same number of treatment options as adults,” Rubio stated. “RACE for Children addresses this problem, and I commend my colleagues for sending this potentially life-saving legislation to the president’s desk so that children with cancer have hope for a better future.”
Bennett added the gauge would result in cutting-edge treatments and precision medicines that could be the game changer for children battling cancer.
“Passage of the RACE for Children Act is a win for kids and families coping with cancer,” Van Hollen said. “No childhood should be interrupted by a struggle for survival, but cancer tragically puts far too many kids in Maryland and across the country in a battle for their lives. The legislation will modernize drug development regulations to help build on the progress being made at institutions like the National Institutes of Health. We won’t stop fighting to save children and their families from the misery of this horrific disease.”